Section Arrow
Quote
PRTC.NASDAQ
- PureTech Health plc
Quotes are at least 15-min delayed:2025/05/24 00:58 EDT
Last
 18.2
-0.8 (-4.21%)
Day High 
19.1699 
Prev. Close
19 
1-M High
19 
Volume 
1.38K 
Bid
16.65
Ask
19.17
Day Low
17.83 
Open
17.83 
1-M Low
15.89 
Market Cap 
456.36M 
Currency USD 
P/E 9.05 
%Yield -- 
10-SMA 17.24 
20-SMA 17.34 
50-SMA 17.37 
52-W High 32.98 
52-W Low 13.3 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
2.10/-4.86
Enterprise Value
471.03M
Balance Sheet
Book Value Per Share
17.27
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
4.32M
Operating Revenue Per Share
0.07
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
PLRZPolyrizon Ltd0.0034-0.0008-19.05%-- 
IMNNImunon1.16+0.7445+179.18%-- 
NCNANuCana plc0.038-0.0014-3.55%-- 
RXRXRecursion Pharmaceuticals4.08-0.065-1.57%-- 
KLTOKlotho Neurosciences Inc0.1923+0.0033+1.75%-- 
Quotes are at least 15-min delayed：2025/05/24 00:58 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, whichderives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.